Weight loss and body mass index as predictors of HIV disease progression to AIDS in adults.: Aquitaine cohort, France, 1985-1997

被引:34
作者
Malvy, D
Thiébaut, R
Marimoutou, C
Dabis, F
机构
[1] Univ Bordeaux 2, Ctr Rene Labusquiere, INSERM, U330, F-33076 Bordeaux, France
[2] CHU Bordeaux, Hop St Andre, Serv Med Interne & Malad Trop, Bordeaux, France
[3] CHU Bordeaux, CISIH, Bordeaux, France
关键词
acquired immunodeficiency syndrome; body mass index; disease progression; HIV infection; weight loss;
D O I
10.1080/07315724.2001.10719065
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Objective: To assess the performance of weight related nutritional markers (reported involuntary weight loss greater than 10%, measured weight loss and body mass index-BMI-) in predicting HIV disease progression. Design: Multirisk cohort of HIV-I infected patients. Method: The three nutritional variables were studied in Cox proportional hazard models as time dependant variables. Results: The sample included 2376 subjects (median follow up: 43.1 months), of those 675 experienced an AIDS defining event. After adjustment for well known prognostic factors, the reported weight loss greater than 10% tripled the risk of progression to clinical AIDS (Hazard ratio [HR] 3.0, 95% confidence interval [CI] 2.5-3.7). For measured weight loss under 5%, between 5% and 10% and greater than 10% of baseline weight compared with no weight loss, hazard ratios were respectively 1.8 (CI 1.5-2.2), 2.6 (CI 2.1-3.2) and 5.1 (CI 4.1-6.4), The relative risks of AIDS were 1.7 (Cl 1.3-2.2) for BMI between 17 kg/m(2) and 18.5 kg/m(2), 2.6 (CI 1.7-4.0) for BMI between 16 kg/m(2) and 17 kg/m(2) and 4.7 (CI 3.0-7.4) for BMI under 16 kg/m(2). Comments: Even a limited weight loss measured at a given time during follow up increases the risk of HIV progression: moreover, a simple cross-sectionnal measure of BMI has a good predictive value for subsequent development of clinical disease.
引用
收藏
页码:609 / 615
页数:7
相关论文
共 35 条
  • [1] Alcabes P, 1997, AM J EPIDEMIOL, V146, P543, DOI 10.1093/oxfordjournals.aje.a009312
  • [2] [Anonymous], 1987, MMWR-MORBID MORTAL W
  • [3] THE PREVALENT COHORT STUDY AND THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME
    BROOKMEYER, R
    GAIL, MH
    POLK, BF
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1987, 126 (01) : 14 - 24
  • [4] [Anonymous], 1992, MMWR Recomm Rep, V41, P1
  • [5] CLARK RA, 1995, J ACQ IMMUN DEF SYND, V9, P43
  • [6] COODLEY GO, 1994, J ACQ IMMUN DEF SYND, V7, P46
  • [7] FERROLUZZI A, 1992, EUR J CLIN NUTR, V46, P173
  • [8] A PROSPECTIVE-STUDY OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 INFECTION AND THE DEVELOPMENT OF AIDS IN SUBJECTS WITH HEMOPHILIA
    GOEDERT, JJ
    KESSLER, CM
    ALEDORT, LM
    BIGGAR, RJ
    ANDES, WA
    WHITE, GC
    DRUMMOND, JE
    VAIDYA, K
    MANN, DL
    EYSTER, ME
    RAGNI, MV
    LEDERMAN, MM
    COHEN, AR
    BRAY, GL
    ROSENBERG, PS
    FRIEDMAN, RM
    HILGARTNER, MW
    BLATTNER, WA
    KRONER, B
    GAIL, MH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (17) : 1141 - 1148
  • [9] Graham Neil M. H., 1994, Annals of Epidemiology, V4, P32, DOI 10.1016/1047-2797(94)90040-X
  • [10] EFFECT OF ZIDOVUDINE AND PNEUMOCYSTIS-CARINII PNEUMONIA PROPHYLAXIS ON PROGRESSION OF HIV-1 INFECTION TO AIDS
    GRAHAM, NMH
    ZEGER, SL
    PARK, LP
    PHAIR, JP
    DETELS, R
    VERMUND, SH
    HO, MT
    SAAH, AJ
    [J]. LANCET, 1991, 338 (8762) : 265 - 269